These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1859896)

  • 1. Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
    Preisler HD; Raza A; Kukla C; Larson R; Goldberg J; Browman G
    Blood; 1991 Aug; 78(3):849-50. PubMed ID: 1859896
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties.
    Zittoun R; Marie JP; Brilhante D; Delmer A
    Haematol Blood Transfus; 1987; 30():45-9. PubMed ID: 3476378
    [No Abstract]   [Full Text] [Related]  

  • 3. Gelatinous transformation of marrow in a case of acute myelogenous leukemia post-chemotherapy.
    Feng CS
    Am J Hematol; 1991 Nov; 38(3):220-2. PubMed ID: 1951321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of cytokinetically based versus intensive chemotherapy for childhood acute myelogenous leukemia.
    Dahl GV; Kalwinsky DK; Mirro J; Look AT
    Haematol Blood Transfus; 1987; 30():83-7. PubMed ID: 3305227
    [No Abstract]   [Full Text] [Related]  

  • 5. Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Longu F; Fozza C; Dessì L; Longinotti M; Bonfigli S; Careddu MG; Coppola L; Giannico DB; Nieddu RM; Podda L; Pardini S; Dore F; Dore S; Sotgiu G
    Acta Haematol; 2017; 137(1):15-16. PubMed ID: 27806360
    [No Abstract]   [Full Text] [Related]  

  • 6. Questions regarding frontline therapy of acute myeloid leukemia.
    Kantarjian H; O'Brien S
    Cancer; 2010 Nov; 116(21):4896-901. PubMed ID: 20623787
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of acute myelogenous leukemia in adults.
    Borthakur G; Estey EE
    Cancer Treat Res; 2010; 145():257-71. PubMed ID: 20306256
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
    Islam A; Catovsky D; Goldman JM; Galton DA
    J Clin Pathol; 1984 Nov; 37(11):1259-63. PubMed ID: 6594351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
    Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
    Roberts MM; Juttner CA; To LB; Kimber RJ
    Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
    Shi P; Zha J; Guo X; Chen F; Fan Z; Huang F; Meng F; Liu X; Feng R; Xu B
    Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract]   [Full Text] [Related]  

  • 14. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
    Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
    Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute nonlymphocytic leukemia].
    Preĭsler KhD; Raza A
    Gematol Transfuziol; 1991 Jan; 36(1):3-8. PubMed ID: 2065944
    [No Abstract]   [Full Text] [Related]  

  • 16. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.
    Roubenoff R; Jones RJ; Karp JE; Stevens MB
    Arthritis Rheum; 1987 Oct; 30(10):1187-90. PubMed ID: 3479115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose cytarabine in acute myelogenous leukemia.
    Zittoun R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR; Velez-Garcia E; Omura G; Raney M
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
    Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
    Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.